Arbutus Biopharma Corp (NASDAQ:ABUS)

Delayed Data
As of Apr 09
 +0.01 / +0.30%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Arbutus Biopharma Corp have a median target of 6.00, with a high estimate of 10.00 and a low estimate of 3.75. The median estimate represents a +82.37% increase from the last price of 3.29.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Arbutus Biopharma Corp. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 06

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.62%
Growthannually 14.00%


Growthquarterly 38.49%
Growthannually 112.41%
Key to the earnings and sales forecast charts.